BioPharma Manufacturing Solutions Inc.

No description available

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G) (amendment)

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G)

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G)

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G)

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G)

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G) (amendment)

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G) (amendment)

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G) (amendment)

General form for quarterly reports under Section 13 or 15(d)

Notification of late filing of Form 10-Q

General form for quarterly reports under Section 13 or 15(d)

Annual report pursuant to Section 13 or 15(d)

Notification of late filing of Form 10-K

General form for quarterly reports under Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

Letter from the SEC

Letter from the SEC

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Correspondence with the SEC

Letter from the SEC

Amended Initial Registration Statement

Annual report pursuant to Section 13 or 15(d) (amendment)

Annual report pursuant to Section 13 or 15(d) (amendment)

Entry into a Material Definitive Agreement

Correspondence with the SEC

Amended Initial Registration Statement

General form for quarterly reports under Section 13 or 15(d)

Letter from the SEC

Amended Initial Registration Statement

Annual report pursuant to Section 13 or 15(d) (amendment)

General form for quarterly reports under Section 13 or 15(d) (amendment)

Entry into a Material Definitive Agreement

Correspondence with the SEC

Notification of late filing of Form 10-K

Annual report pursuant to Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d) (amendment)

General form for quarterly reports under Section 13 or 15(d) (amendment)

Letter from the SEC

General form for quarterly reports under Section 13 or 15(d)

Notification of late filing of Form 10-Q

06b

1.01,2.01,3.02,5.06,9.01

Amended Initial Registration Statement

General form for quarterly reports under Section 13 or 15(d)

Notification of late filing of Form 10-Q

Letter from the SEC

Letter from the SEC

Letter from the SEC

1.01,2.01,3.02,5.06,9.01

Amended Initial Registration Statement

06

Letter from the SEC

2.01,3.02,5.06,9.01

Registration (IPO) statement under Securities Act of 1933

Letter from the SEC

Letter from the SEC

Unregistered Sales of Equity Securities

3.02,5.01,5.02,5.03

Letter from the SEC

3.02,5.01,5.02,5.03

No description available

Letter from the SEC

No description available

MB Americus LLC

MB Americus LLC

Tiber Creek CORP

CASSIDY JAMES M

CASSIDY JAMES M

McKillop James K

McKillop James K

Tiber Creek CORP